Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

In vitro reconstitution of complexes between pro-matrix metalloproteinase-9 and the proteoglycans serglycin and versican.

Malla N, Berg E, Theocharis AD, Svineng G, Uhlin-Hansen L, Winberg JO.

FEBS J. 2013 Jun;280(12):2870-87. doi: 10.1111/febs.12291. Epub 2013 May 9.

2.

Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen.

Malla N, Berg E, Uhlin-Hansen L, Winberg JO.

J Biol Chem. 2008 May 16;283(20):13652-65. doi: 10.1074/jbc.M709140200. Epub 2008 Mar 20.

3.

Biosynthesis of promatrix metalloproteinase-9/chondroitin sulphate proteoglycan heteromer involves a Rottlerin-sensitive pathway.

Malla N, Berg E, Moens U, Uhlin-Hansen L, Winberg JO.

PLoS One. 2011;6(6):e20616. doi: 10.1371/journal.pone.0020616. Epub 2011 Jun 1.

4.

Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans.

Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L.

J Mol Biol. 2000 Dec 8;304(4):669-80.

PMID:
11099388
5.
6.

Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M.

EMBO J. 2001 Sep 3;20(17):4782-93.

7.
8.

Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.

Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H.

Biochem J. 1992 Jul 15;285 ( Pt 2):603-11.

9.

Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Vandooren J, Born B, Solomonov I, Zajac E, Saldova R, Senske M, Ugarte-Berzal E, Martens E, Van den Steen PE, Van Damme J, Garcia-Pardo A, Froeyen M, Deryugina EI, Quigley JP, Moestrup SK, Rudd PM, Sagi I, Opdenakker G.

Biochem J. 2015 Jan 15;465(2):259-70. doi: 10.1042/BJ20140418.

11.

Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.

Fujimoto N, Ward RV, Shinya T, Iwata K, Yamashita K, Hayakawa T.

Biochem J. 1996 Feb 1;313 ( Pt 3):827-33.

12.
13.
14.
15.

Characterization of chondroitin/dermatan sulfate proteoglycans synthesized by bovine retinal pericytes in culture.

Kaji T, Sakurai S, Yamamoto C, Fujiwara Y, Yamagishi S, Yamamoto H, Kinsella MG, Wight TN.

Biol Pharm Bull. 2004 Nov;27(11):1763-8.

16.

Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican.

Thomas GJ, Bayliss MT, Harper K, Mason RM, Davies M.

Biochem J. 1994 Aug 15;302 ( Pt 1):49-56.

17.

Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.

Biochem J. 2003 Jun 15;372(Pt 3):799-809.

19.

Supplemental Content

Support Center